ID UCK2_HUMAN Reviewed; 261 AA. AC Q9BZX2; Q5VV91; Q7KZV3; Q92528; Q96KG5; Q9BU42; DT 02-MAY-2002, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 27-MAR-2024, entry version 191. DE RecName: Full=Uridine-cytidine kinase 2; DE Short=UCK 2; DE EC=2.7.1.48 {ECO:0000269|PubMed:11306702, ECO:0000269|PubMed:11494055}; DE AltName: Full=Cytidine monophosphokinase 2; DE AltName: Full=Testis-specific protein TSA903; DE AltName: Full=Uridine monophosphokinase 2; GN Name=UCK2; Synonyms=UMPK; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY. RX PubMed=8812458; DOI=10.1006/geno.1996.0467; RA Ozaki K., Kuroki T., Hayashi S., Nakamura Y.; RT "Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a RT differential mRNA display method."; RL Genomics 36:316-319(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND RP PATHWAY. RX PubMed=11306702; DOI=10.1124/mol.59.5.1181; RA Van Rompay A.R., Norda A., Linden K., Johansson M., Karlsson A.; RT "Phosphorylation of uridine and cytidine nucleoside analogs by two human RT uridine-cytidine kinases."; RL Mol. Pharmacol. 59:1181-1186(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] OF 15-261 (ISOFORM 1), FUNCTION, CATALYTIC RP ACTIVITY, AND PATHWAY. RC TISSUE=Fibrosarcoma; RX PubMed=11494055; RA Koizumi K., Shimamoto Y., Azuma A., Wataya Y., Matsuda A., Sasaki T., RA Fukushima M.; RT "Cloning and expression of uridine/cytidine kinase cDNA from human RT fibrosarcoma cells."; RL Int. J. Mol. Med. 8:273-278(2001). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007; RA Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., RA Greff Z., Keri G., Stemmann O., Mann M.; RT "Kinase-selective enrichment enables quantitative phosphoproteomics of the RT kinome across the cell cycle."; RL Mol. Cell 31:438-448(2008). RN [9] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [12] RP X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-250 IN COMPLEXES WITH ADP; RP CYTIDINE; CMP; CTP AND UTP, AND SUBUNIT. RX PubMed=15130468; DOI=10.1016/j.str.2004.02.038; RA Suzuki N.N., Koizumi K., Fukushima M., Matsuda A., Inagaki F.; RT "Structural basis for the specificity, catalysis, and regulation of human RT uridine-cytidine kinase."; RL Structure 12:751-764(2004). RN [13] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH ADP AND CMP, AND RP SUBUNIT. RX PubMed=15735337; DOI=10.1107/s0907444904032937; RA Appleby T.C., Larson G., Cheney I.W., Walker H., Wu J.Z., Zhong W., RA Hong Z., Yao N.; RT "Structure of human uridine-cytidine kinase 2 determined by SIRAS using a RT rotating-anode X-ray generator and a single samarium derivative."; RL Acta Crystallogr. D 61:278-284(2005). CC -!- FUNCTION: Phosphorylates uridine and cytidine to uridine monophosphate CC and cytidine monophosphate (PubMed:11306702, PubMed:11494055). Does not CC phosphorylate deoxyribonucleosides or purine ribonucleosides CC (PubMed:11306702). Can use ATP or GTP as a phosphate donor CC (PubMed:11306702). Can also phosphorylate cytidine and uridine CC nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4- CC thiouridine, 5-bromouridine, N(4)-acetylcytidine, N(4)-benzoylcytidine, CC 5-fluorocytidine, 2-thiocytidine, 5-methylcytidine, and N(4)- CC anisoylcytidine (PubMed:11306702). {ECO:0000269|PubMed:11306702, CC ECO:0000269|PubMed:11494055}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + uridine = ADP + H(+) + UMP; Xref=Rhea:RHEA:16825, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16704, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:57865, ChEBI:CHEBI:456216; EC=2.7.1.48; CC Evidence={ECO:0000269|PubMed:11306702, ECO:0000269|PubMed:11494055}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + cytidine = ADP + CMP + H(+); Xref=Rhea:RHEA:24674, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:17562, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:60377, ChEBI:CHEBI:456216; EC=2.7.1.48; CC Evidence={ECO:0000269|PubMed:11306702, ECO:0000269|PubMed:11494055}; CC -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via salvage pathway; CC CTP from cytidine: step 1/3. {ECO:0000269|PubMed:11306702, CC ECO:0000269|PubMed:11494055}. CC -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via salvage pathway; CC UMP from uridine: step 1/1. {ECO:0000269|PubMed:11306702, CC ECO:0000269|PubMed:11494055}. CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15130468, CC ECO:0000269|PubMed:15735337}. CC -!- INTERACTION: CC Q9BZX2; Q9BZX2: UCK2; NbExp=3; IntAct=EBI-1053938, EBI-1053938; CC Q9BZX2-1; Q9BZX2-1: UCK2; NbExp=2; IntAct=EBI-21013535, EBI-21013535; CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9BZX2-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9BZX2-2; Sequence=VSP_014262; CC -!- TISSUE SPECIFICITY: According to PubMed:8812458; testis-specific. CC According to PubMed:11306702, placenta-specific. CC {ECO:0000269|PubMed:8812458}. CC -!- SIMILARITY: Belongs to the uridine kinase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D78335; BAA11349.1; -; mRNA. DR EMBL; AF236637; AAK14053.1; -; mRNA. DR EMBL; BT006860; AAP35506.1; -; mRNA. DR EMBL; CR456857; CAG33138.1; -; mRNA. DR EMBL; AL451074; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL358115; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC002906; AAH02906.2; -; mRNA. DR EMBL; AB062451; BAB56162.1; -; mRNA. DR CCDS; CCDS1252.1; -. [Q9BZX2-1] DR RefSeq; NP_036606.2; NM_012474.4. [Q9BZX2-1] DR PDB; 1UDW; X-ray; 2.60 A; A/B=1-250. DR PDB; 1UEI; X-ray; 2.60 A; A/B=1-250. DR PDB; 1UEJ; X-ray; 2.61 A; A/B=1-250. DR PDB; 1UFQ; X-ray; 2.50 A; A/B/C/D=1-250. DR PDB; 1UJ2; X-ray; 1.80 A; A/B=1-250. DR PDB; 1XRJ; X-ray; 2.00 A; A/B=1-261. DR PDB; 6N53; X-ray; 2.70 A; A/B=1-250. DR PDB; 6N54; X-ray; 2.42 A; A/B=1-250. DR PDB; 6N55; X-ray; 3.08 A; A/B/C/D/E/F/G/H=1-250. DR PDB; 6PWZ; X-ray; 3.00 A; A/B/C/D/E/F/G/H=1-250. DR PDB; 7SQL; X-ray; 2.40 A; A/B/C/D=1-250. DR PDBsum; 1UDW; -. DR PDBsum; 1UEI; -. DR PDBsum; 1UEJ; -. DR PDBsum; 1UFQ; -. DR PDBsum; 1UJ2; -. DR PDBsum; 1XRJ; -. DR PDBsum; 6N53; -. DR PDBsum; 6N54; -. DR PDBsum; 6N55; -. DR PDBsum; 6PWZ; -. DR PDBsum; 7SQL; -. DR AlphaFoldDB; Q9BZX2; -. DR SMR; Q9BZX2; -. DR BioGRID; 113217; 75. DR IntAct; Q9BZX2; 11. DR STRING; 9606.ENSP00000356853; -. DR BindingDB; Q9BZX2; -. DR ChEMBL; CHEMBL2469; -. DR DrugBank; DB02097; Cytidine. DR DrugBank; DB03403; Cytidine-5'-Monophosphate. DR DrugBank; DB02431; Cytidine-5'-Triphosphate. DR DrugBank; DB04005; Uridine 5'-triphosphate. DR DrugCentral; Q9BZX2; -. DR GlyCosmos; Q9BZX2; 1 site, 1 glycan. DR GlyGen; Q9BZX2; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q9BZX2; -. DR PhosphoSitePlus; Q9BZX2; -. DR BioMuta; UCK2; -. DR DMDM; 20455356; -. DR EPD; Q9BZX2; -. DR jPOST; Q9BZX2; -. DR MassIVE; Q9BZX2; -. DR MaxQB; Q9BZX2; -. DR PaxDb; 9606-ENSP00000356853; -. DR PeptideAtlas; Q9BZX2; -. DR ProteomicsDB; 79917; -. [Q9BZX2-1] DR ProteomicsDB; 79918; -. [Q9BZX2-2] DR Pumba; Q9BZX2; -. DR Antibodypedia; 34333; 223 antibodies from 27 providers. DR DNASU; 7371; -. DR Ensembl; ENST00000367879.9; ENSP00000356853.4; ENSG00000143179.16. [Q9BZX2-1] DR Ensembl; ENST00000469256.6; ENSP00000476692.1; ENSG00000143179.16. [Q9BZX2-2] DR Ensembl; ENST00000470820.1; ENSP00000476327.1; ENSG00000143179.16. [Q9BZX2-2] DR GeneID; 7371; -. DR KEGG; hsa:7371; -. DR MANE-Select; ENST00000367879.9; ENSP00000356853.4; NM_012474.5; NP_036606.2. DR UCSC; uc021pec.2; human. [Q9BZX2-1] DR AGR; HGNC:12562; -. DR CTD; 7371; -. DR DisGeNET; 7371; -. DR GeneCards; UCK2; -. DR HGNC; HGNC:12562; UCK2. DR HPA; ENSG00000143179; Low tissue specificity. DR MIM; 609329; gene. DR neXtProt; NX_Q9BZX2; -. DR OpenTargets; ENSG00000143179; -. DR PharmGKB; PA362; -. DR VEuPathDB; HostDB:ENSG00000143179; -. DR eggNOG; KOG4203; Eukaryota. DR GeneTree; ENSGT01020000230412; -. DR HOGENOM; CLU_021278_1_1_1; -. DR InParanoid; Q9BZX2; -. DR OMA; TVKPMHE; -. DR OrthoDB; 180154at2759; -. DR PhylomeDB; Q9BZX2; -. DR TreeFam; TF316686; -. DR BioCyc; MetaCyc:HS07003-MONOMER; -. DR BRENDA; 2.7.1.48; 2681. DR PathwayCommons; Q9BZX2; -. DR Reactome; R-HSA-73614; Pyrimidine salvage. DR SABIO-RK; Q9BZX2; -. DR SignaLink; Q9BZX2; -. DR UniPathway; UPA00574; UER00637. DR UniPathway; UPA00579; UER00640. DR BioGRID-ORCS; 7371; 22 hits in 1163 CRISPR screens. DR ChiTaRS; UCK2; human. DR EvolutionaryTrace; Q9BZX2; -. DR GeneWiki; UCK2; -. DR GenomeRNAi; 7371; -. DR Pharos; Q9BZX2; Tbio. DR PRO; PR:Q9BZX2; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q9BZX2; Protein. DR Bgee; ENSG00000143179; Expressed in mucosa of transverse colon and 157 other cell types or tissues. DR ExpressionAtlas; Q9BZX2; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0043771; F:cytidine kinase activity; IDA:UniProtKB. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0004849; F:uridine kinase activity; IDA:UniProtKB. DR GO; GO:0044211; P:CTP salvage; IDA:UniProtKB. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0044206; P:UMP salvage; IDA:UniProtKB. DR CDD; cd02023; UMPK; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR006083; PRK/URK. DR InterPro; IPR000764; Uridine_kinase-like. DR NCBIfam; TIGR00235; udk; 1. DR PANTHER; PTHR10285; URIDINE KINASE; 1. DR PANTHER; PTHR10285:SF131; URIDINE-CYTIDINE KINASE 2; 1. DR Pfam; PF00485; PRK; 1. DR PRINTS; PR00988; URIDINKINASE. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR Genevisible; Q9BZX2; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; ATP-binding; Kinase; KW Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:19413330" FT CHAIN 2..261 FT /note="Uridine-cytidine kinase 2" FT /id="PRO_0000164455" FT REGION 1..24 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 236..261 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1..17 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 236..253 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 27..35 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 84 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 112 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 117 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 166 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 176 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 184 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT BINDING 213 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000269|PubMed:15130468, FT ECO:0000269|PubMed:15735337" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:19413330" FT MOD_RES 254 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21406692" FT VAR_SEQ 1..150 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:8812458, ECO:0000303|Ref.3, FT ECO:0000303|Ref.4" FT /id="VSP_014262" FT CONFLICT 202 FT /note="K -> Q (in Ref. 1; BAA11349)" FT /evidence="ECO:0000305" FT CONFLICT 222 FT /note="V -> E (in Ref. 1; BAA11349)" FT /evidence="ECO:0000305" FT STRAND 21..26 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 33..43 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 46..48 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 51..53 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 55..60 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 61..64 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 70..77 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 86..88 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 91..102 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 107..113 FT /evidence="ECO:0007829|PDB:1UJ2" FT TURN 114..117 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 118..126 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 130..135 FT /evidence="ECO:0007829|PDB:1UJ2" FT TURN 137..140 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 143..148 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 150..156 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 159..173 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 178..187 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 189..196 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 198..203 FT /evidence="ECO:0007829|PDB:1UJ2" FT STRAND 205..209 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 211..213 FT /evidence="ECO:0007829|PDB:1UJ2" FT HELIX 215..230 FT /evidence="ECO:0007829|PDB:1UJ2" SQ SEQUENCE 261 AA; 29299 MW; 71791346F091EBFD CRC64; MAGDSEQTLQ NHQQPNGGEP FLIGVSGGTA SGKSSVCAKI VQLLGQNEVD YRQKQVVILS QDSFYRVLTS EQKAKALKGQ FNFDHPDAFD NELILKTLKE ITEGKTVQIP VYDFVSHSRK EETVTVYPAD VVLFEGILAF YSQEVRDLFQ MKLFVDTDAD TRLSRRVLRD ISERGRDLEQ ILSQYITFVK PAFEEFCLPT KKYADVIIPR GADNLVAINL IVQHIQDILN GGPSKRQTNG CLNGYTPSRK RQASESSSRP H //